LivaNova

Update in progress

LIVN (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

LivaNova PLC is a medical technology company that designs, develops, manufactures, markets and sells cardiopulmonary and neuromodulation products worldwide. Cardiopulmonary offerings include heart-lung machines, oxygenators, perfusion tubing, cannulae and related services. Neuromodulation includes the VNS Therapy System (implantable pulse generator and lead), surgical equipment, and devices for drug-resistant epilepsy and refractory depression, plus aura6000 sleep apnea work in development. Sells through direct sales, agents and distributors. Incorporated 2015, HQ in London.

Company score

Sentiment: 0.35; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.38; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.36; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive